NCT05330065 2022-04-15
A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion
The First Affiliated Hospital of Zhengzhou University
Phase 1/2 Unknown
Clinical Trials
3 trialsNCT02942043 2018-11-07
Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT02054078 2014-02-04
Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion
Tang-Du Hospital
Phase 2 Unknown